Deciphering the role of protein kinase A in the control of FoxP3 expression in regulatory T cells in health and autoimmunity.

Humans Forkhead Transcription Factors / metabolism T-Lymphocytes, Regulatory / immunology Cyclic AMP-Dependent Protein Kinases / metabolism Cyclic AMP Response Element-Binding Protein / metabolism Autoimmunity Phosphorylation Gene Expression Regulation Multiple Sclerosis / immunology Female Male

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 Jul 2024
Historique:
received: 06 09 2023
accepted: 18 07 2024
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 30 7 2024
Statut: epublish

Résumé

The molecular mechanisms that govern differential T cell development from CD4

Identifiants

DOI: 10.1038/s41598-024-68098-z PMID: 39080325
pubmed: 39080325
doi: 10.1038/s41598-024-68098-z
pii: 10.1038/s41598-024-68098-z
doi:

Substances chimiques

Forkhead Transcription Factors 0
FOXP3 protein, human 0
Cyclic AMP-Dependent Protein Kinases EC 2.7.11.11
Cyclic AMP Response Element-Binding Protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17571

Informations de copyright

© 2024. The Author(s).

Références

Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775–787. https://doi.org/10.1016/j.cell.2008.05.009 (2008).
doi: 10.1016/j.cell.2008.05.009 pubmed: 18510923
Kawai, K., Uchiyama, M., Hester, J., Wood, K. & Issa, F. Regulatory T cells for tolerance. Hum. Immunol. 79, 294–303. https://doi.org/10.1016/j.humimm.2017.12.013 (2018).
doi: 10.1016/j.humimm.2017.12.013 pubmed: 29288698
Dikiy, S. & Rudensky, A. Y. Principles of regulatory T cell function. Immunity 56, 240–255. https://doi.org/10.1016/j.immuni.2023.01.004 (2023).
doi: 10.1016/j.immuni.2023.01.004 pubmed: 36792571
Joosten, S. A. & Ottenhoff, T. H. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum. Immunol. 69, 760–770. https://doi.org/10.1016/j.humimm.2008.07.017 (2008).
doi: 10.1016/j.humimm.2008.07.017 pubmed: 18835413
Santamaria, J. C., Borelli, A. & Irla, M. Regulatory T cell heterogeneity in the thymus: impact on their functional activities. Front. Immunol. 12, 643153. https://doi.org/10.3389/fimmu.2021.643153 (2021).
doi: 10.3389/fimmu.2021.643153 pubmed: 33643324 pmcid: 7904894
Bolivar-Wagers, S., Larson, J. H., Jin, S. & Blazar, B. R. Cytolytic CD4(+) and CD8(+) regulatory T-cells and implications for developing immunotherapies to combat graft-versus-host disease. Front. Immunol. 13, 864748. https://doi.org/10.3389/fimmu.2022.864748 (2022).
doi: 10.3389/fimmu.2022.864748 pubmed: 35493508 pmcid: 9040077
Grover, P., Goel, P. N. & Greene, M. I. Regulatory T cells: Regulation of identity and function. Front. Immunol. 12, 750542. https://doi.org/10.3389/fimmu.2021.750542 (2021).
doi: 10.3389/fimmu.2021.750542 pubmed: 34675933 pmcid: 8524049
Sakaguchi, S. et al. Regulatory T cells and human disease. Annu. Rev. Immunol. 38, 541–566. https://doi.org/10.1146/annurev-immunol-042718-041717 (2020).
doi: 10.1146/annurev-immunol-042718-041717 pubmed: 32017635
Curotto de Lafaille, M. A. & Lafaille, J. J. Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor?. Immunity 30, 626–635. https://doi.org/10.1016/j.immuni.2009.05.002 (2009).
doi: 10.1016/j.immuni.2009.05.002 pubmed: 19464985
De Rosa, V. et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat. Immunol. 16, 1174–1184. https://doi.org/10.1038/ni.3269 (2015).
doi: 10.1038/ni.3269 pubmed: 26414764 pmcid: 4868085
Sauer, S. et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U. S. A. 105, 7797–7802. https://doi.org/10.1073/pnas.0800928105 (2008).
doi: 10.1073/pnas.0800928105 pubmed: 18509048 pmcid: 2409380
Bruzzaniti, S. et al. An immunometabolic pathomechanism for chronic obstructive pulmonary disease. Proc. Natl. Acad. Sci. U. S. A. 116, 15625–15634. https://doi.org/10.1073/pnas.1906303116 (2019).
doi: 10.1073/pnas.1906303116 pubmed: 31308239 pmcid: 6681742
Shevach, E. M. & Thornton, A. M. tTregs, pTregs, and iTregs: Similarities and differences. Immunol. Rev. 259, 88–102. https://doi.org/10.1111/imr.12160 (2014).
doi: 10.1111/imr.12160 pubmed: 24712461 pmcid: 3982187
Chen, W. et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886. https://doi.org/10.1084/jem.20030152 (2003).
doi: 10.1084/jem.20030152 pubmed: 14676299 pmcid: 2194145
Hernandez, R., Põder, J., LaPorte, K. M. & Malek, T. R. Engineering IL-2 for immunotherapy of autoimmunity and cancer. Nat. Rev. Immunol. 22, 614–628. https://doi.org/10.1038/s41577-022-00680-w (2022).
doi: 10.1038/s41577-022-00680-w pubmed: 35217787
Giri, P. S. & Dwivedi, M. Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients. Pigment Cell Melanoma Res. 33, 566–578. https://doi.org/10.1111/pcmr.12862 (2020).
doi: 10.1111/pcmr.12862 pubmed: 31917889
Chen, W. TGF-β regulation of T cells. Annu. Rev. Immunol. 41, 483–512. https://doi.org/10.1146/annurev-immunol-101921-045939 (2023).
doi: 10.1146/annurev-immunol-101921-045939 pubmed: 36750317
Chinen, T. et al. An essential role for the IL-2 receptor in Treg cell function. Nat. Immunol. 17, 1322–1333. https://doi.org/10.1038/ni.3540 (2016).
doi: 10.1038/ni.3540 pubmed: 27595233 pmcid: 5071159
Chen, W. & Konkel, J. E. Development of thymic Foxp3(+) regulatory T cells: TGF-beta matters. Eur. J. Immunol. 45, 958–965. https://doi.org/10.1002/eji.201444999 (2015).
doi: 10.1002/eji.201444999 pubmed: 25684698 pmcid: 4428761
Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219–1227. https://doi.org/10.1038/ni1265 (2005).
doi: 10.1038/ni1265 pubmed: 16244650
Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330–336. https://doi.org/10.1038/ni904 (2003).
doi: 10.1038/ni904 pubmed: 12612578
Abbas, A. K. et al. Regulatory T cells: Recommendations to simplify the nomenclature. Nat. Immunol. 14, 307–308. https://doi.org/10.1038/ni.2554 (2013).
doi: 10.1038/ni.2554 pubmed: 23507634
Ohkura, N., Kitagawa, Y. & Sakaguchi, S. Development and maintenance of regulatory T cells. Immunity 38, 414–423. https://doi.org/10.1016/j.immuni.2013.03.002 (2013).
doi: 10.1016/j.immuni.2013.03.002 pubmed: 23521883
Colamatteo, A. et al. Metabolism and autoimmune responses: The microRNA connection. Front. Immunol. 10, 1969. https://doi.org/10.3389/fimmu.2019.01969 (2019).
doi: 10.3389/fimmu.2019.01969 pubmed: 31555261 pmcid: 6722206
Kawakami, R. et al. Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells. Immunity 54, 947-961.e948. https://doi.org/10.1016/j.immuni.2021.04.005 (2021).
doi: 10.1016/j.immuni.2021.04.005 pubmed: 33930308
Mailer, R. K. W. Alternative splicing of FOXP3-virtue and vice. Front. Immunol. 9, 530. https://doi.org/10.3389/fimmu.2018.00530 (2018).
doi: 10.3389/fimmu.2018.00530 pubmed: 29593749 pmcid: 5859138
Melis, D. et al. Cutting edge: Increased autoimmunity risk in glycogen storage disease type 1b Is Associated with a reduced engagement of glycolysis in T cells and an impaired regulatory T cell function. J. Immunol. 198, 3803–3808. https://doi.org/10.4049/jimmunol.1601946 (2017).
doi: 10.4049/jimmunol.1601946 pubmed: 28389590 pmcid: 5421305
Du, J., Wang, Q. & Yang, S. FOXP3 exon 2 controls T(reg) stability and autoimmunity. Sci. Immunol. 7, eabo5407. https://doi.org/10.1126/sciimmunol.abo5407 (2022).
doi: 10.1126/sciimmunol.abo5407 pubmed: 35749515 pmcid: 9333337
Pesenacker, A. M., Cook, L. & Levings, M. K. The role of FOXP3 in autoimmunity. Curr. Opin. Immunol. 43, 16–23. https://doi.org/10.1016/j.coi.2016.07.004 (2016).
doi: 10.1016/j.coi.2016.07.004 pubmed: 27544816
Wing, J. B., Tanaka, A. & Sakaguchi, S. Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50, 302–316. https://doi.org/10.1016/j.immuni.2019.01.020 (2019).
doi: 10.1016/j.immuni.2019.01.020 pubmed: 30784578
Kuhlmann, T. et al. Multiple sclerosis progression: Time for a new mechanism-driven framework. The Lancet Neurol. 22, 78–88. https://doi.org/10.1016/s1474-4422(22)00289-7 (2023).
doi: 10.1016/s1474-4422(22)00289-7 pubmed: 36410373
Ogawa, C. et al. TGF-beta-mediated Foxp3 gene expression is cooperatively regulated by Stat5, Creb, and AP-1 through CNS2. J. Immunol. 192, 475–483. https://doi.org/10.4049/jimmunol.1301892 (2014).
doi: 10.4049/jimmunol.1301892 pubmed: 24298014
Kim, H. P. & Leonard, W. J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204, 1543–1551. https://doi.org/10.1084/jem.20070109 (2007).
doi: 10.1084/jem.20070109 pubmed: 17591856 pmcid: 2118651
Wang, X. et al. Cyclic AMP-Responsive element-binding protein (CREB) is critical in autoimmunity by promoting Th17 but inhibiting treg cell differentiation. EBioMedicine 25, 165–174. https://doi.org/10.1016/j.ebiom.2017.10.010 (2017).
doi: 10.1016/j.ebiom.2017.10.010 pubmed: 29050947 pmcid: 5704088
Mosenden, R. & Tasken, K. Cyclic AMP-mediated immune regulation—overview of mechanisms of action in T cells. Cell. Signal. 23, 1009–1016. https://doi.org/10.1016/j.cellsig.2010.11.018 (2011).
doi: 10.1016/j.cellsig.2010.11.018 pubmed: 21130867
Arumugham, V. B. & Baldari, C. T. cAMP: A multifaceted modulator of immune synapse assembly and T cell activation. J. Leukoc. Biol. 101, 1301–1316. https://doi.org/10.1189/jlb.2RU1116-474R (2017).
doi: 10.1189/jlb.2RU1116-474R pubmed: 28356349
Murray, A. J. Pharmacological PKA inhibition: All may not be what it seems. Sci. Signal. 1, re4. https://doi.org/10.1126/scisignal.122re4 (2008).
doi: 10.1126/scisignal.122re4 pubmed: 18523239
Lochner, A. & Moolman, J. A. The many faces of H89: A review. Cardiovasc. Drug Rev. 24, 261–274. https://doi.org/10.1111/j.1527-3466.2006.00261.x (2006).
doi: 10.1111/j.1527-3466.2006.00261.x pubmed: 17214602
Wen, A. Y., Sakamoto, K. M. & Miller, L. S. The role of the transcription factor CREB in immune function. J. Immunol. 185, 6413–6419. https://doi.org/10.4049/jimmunol.1001829 (2010).
doi: 10.4049/jimmunol.1001829 pubmed: 21084670
Haxhinasto, S., Mathis, D. & Benoist, C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565–574. https://doi.org/10.1084/jem.20071477 (2008).
doi: 10.1084/jem.20071477 pubmed: 18283119 pmcid: 2275380
Turner, M. S., Kane, L. P. & Morel, P. A. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. J. Immunol. 183, 4895–4903. https://doi.org/10.4049/jimmunol.0901459 (2009).
doi: 10.4049/jimmunol.0901459 pubmed: 19801514
Huang, H., Long, L., Zhou, P., Chapman, N. M. & Chi, H. mTOR signaling at the crossroads of environmental signals and T-cell fate decisions. Immunol. Rev. 295, 15–38. https://doi.org/10.1111/imr.12845 (2020).
doi: 10.1111/imr.12845 pubmed: 32212344 pmcid: 8101438
Pearce, E. L., Poffenberger, M. C., Chang, C. H. & Jones, R. G. Fueling immunity: Insights into metabolism and lymphocyte function. Science 342, 1242454. https://doi.org/10.1126/science.1242454 (2013).
doi: 10.1126/science.1242454 pubmed: 24115444 pmcid: 4486656
Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808–812. https://doi.org/10.1038/nature08750 (2010).
doi: 10.1038/nature08750 pubmed: 20072126 pmcid: 2884187
Oda, J. M., Hirata, B. K., Guembarovski, R. L. & Watanabe, M. A. Genetic polymorphism in FOXP3 gene: Imbalance in regulatory T-cell role and development of human diseases. J. Genet. 92, 163–171. https://doi.org/10.1007/s12041-013-0213-7 (2013).
doi: 10.1007/s12041-013-0213-7 pubmed: 23640423
Shi, H. & Chi, H. Metabolic control of treg cell stability, plasticity, and tissue-specific heterogeneity. Front. Immunol. 10, 2716. https://doi.org/10.3389/fimmu.2019.02716 (2019).
doi: 10.3389/fimmu.2019.02716 pubmed: 31921097 pmcid: 6917616
Galgani, M., Bruzzaniti, S. & Matarese, G. Immunometabolism and autoimmunity. Curr. Opin. Immunol. 67, 10–17. https://doi.org/10.1016/j.coi.2020.07.002 (2020).
doi: 10.1016/j.coi.2020.07.002 pubmed: 32784085
Jungmann, R. A. & Kiryukhina, O. Cyclic AMP and AKAP-mediated targeting of protein kinase A regulates lactate dehydrogenase subunit A mRNA stability. J. Biol. Chem. 280, 25170–25177. https://doi.org/10.1074/jbc.M502514200 (2005).
doi: 10.1074/jbc.M502514200 pubmed: 15878851
Tian, D., Huang, D., Brown, R. C. & Jungmann, R. A. Protein kinase A stimulates binding of multiple proteins to a U-rich domain in the 3’-untranslated region of lactate dehydrogenase A mRNA that is required for the regulation of mRNA stability. J. Biol. Chem. 273, 28454–28460. https://doi.org/10.1074/jbc.273.43.28454 (1998).
doi: 10.1074/jbc.273.43.28454 pubmed: 9774474
Zhang, T. et al. Adenosine influences Foxp3 expression of T regs via the A2ar/Creb pathway in a mouse model of sepsis. Shock 61, 924–933. https://doi.org/10.1097/SHK.0000000000002281 (2024).
doi: 10.1097/SHK.0000000000002281 pubmed: 38010286
Clark, B. J. & Hudson, E. A. StAR protein stability in Y1 and Kin-8 mouse adrenocortical cells. Biology (Basel) 4, 200–215. https://doi.org/10.3390/biology4010200 (2015).
doi: 10.3390/biology4010200 pubmed: 25749137
Liu, Q., Nguyen, E., Doskeland, S. & Segal-Bendirdjian, E. cAMP-dependent protein kinase A (PKA)-mediated c-myc degradation is dependent on the relative proportion of PKA-I and PKA-II isozymes. Mol. Pharmacol. 88, 469–476. https://doi.org/10.1124/mol.115.097915 (2015).
doi: 10.1124/mol.115.097915 pubmed: 26104548
Kempkes, R. W. M., Joosten, I., Koenen, H. & He, X. Metabolic pathways involved in regulatory T cell functionality. Front. Immunol. 10, 2839. https://doi.org/10.3389/fimmu.2019.02839 (2019).
doi: 10.3389/fimmu.2019.02839 pubmed: 31849995 pmcid: 6902900
La Rocca, C. et al. Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration. Metabolism 77, 39–46. https://doi.org/10.1016/j.metabol.2017.08.011 (2017).
doi: 10.1016/j.metabol.2017.08.011 pubmed: 29132538 pmcid: 5800394
Galgani, M. et al. Regulatory T cells, inflammation, and endoplasmic reticulum stress in women with defective endometrial receptivity. Fertil. Steril. 103, 1579–1586. https://doi.org/10.1016/j.fertnstert.2015.03.014 (2015).
doi: 10.1016/j.fertnstert.2015.03.014 pubmed: 25935494
De Rosa, V. et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241–255. https://doi.org/10.1016/j.immuni.2007.01.011 (2007).
doi: 10.1016/j.immuni.2007.01.011 pubmed: 17307705

Auteurs

Maria Teresa Lepore (MT)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.

Sara Bruzzaniti (S)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.

Claudia La Rocca (C)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.

Clorinda Fusco (C)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II", Naples, Italy.

Fortunata Carbone (F)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.
Unità di Neuroimmunologia, IRCCS Fondazione Santa Lucia, Rome, Italy.

Maria Mottola (M)

UOC di Medicina Trasfusionale, AORN Ospedale dei Colli, Ospedale Monaldi, Naples, Italy.

Bruno Zuccarelli (B)

UOC di Medicina Trasfusionale, AORN Ospedale dei Colli, Ospedale Monaldi, Naples, Italy.

Roberta Lanzillo (R)

Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche, Università degli Studi di Napoli "Federico II", Naples, Italy.

Vincenzo Brescia Morra (V)

Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche, Università degli Studi di Napoli "Federico II", Naples, Italy.

Giorgia Teresa Maniscalco (GT)

Dipartimento di Neurologia, Centro Regionale Sclerosi Multipla, Azienda Ospedaliera "A. Cardarelli", Naples, Italy.

Salvatore De Simone (S)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.

Claudio Procaccini (C)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.
Unità di Neuroimmunologia, IRCCS Fondazione Santa Lucia, Rome, Italy.

Antonio Porcellini (A)

Dipartimento di Biologia, Università degli Studi di Napoli "Federico II", Naples, Italy.
ORCID: 0000-0001-6882-9518

Veronica De Rosa (V)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.

Mario Galgani (M)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II", Naples, Italy.

Silvana Cassano (S)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy.

Giuseppe Matarese (G)

Laboratorio di Immunologia, Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", Consiglio Nazionale delle Ricerche, Naples, Italy. giuseppe.matarese@unina.it.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II", Naples, Italy. giuseppe.matarese@unina.it.
ORCID: 0000-0001-9429-0616

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Deciphering the role of protein kinase A in...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription à motif hélice ailée › Facteurs de transcription Forkhead › Deciphering the role of protein kinase A in...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T régulateurs › Deciphering the role of protein kinase A in...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines et peptides de signalisation intracellulaire › Protein-Serine-Threonine Kinases › Cyclic Nucleotide-Regulated Protein Kinases › Cyclic AMP-Dependent Protein Kinases › Deciphering the role of protein kinase A in...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription à motif basique et à glissière à leucines › Protéine de liaison à l'élément de réponse à l'AMP cyclique › Deciphering the role of protein kinase A in...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Auto-immunité › Deciphering the role of protein kinase A in...
questionsmedicales.fr › Métabolisme › Phosphorylation › Deciphering the role of protein kinase A in...
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Deciphering the role of protein kinase A in...
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Maladies auto-immunes du système nerveux › Maladies démyélinisantes auto-immunes du SNC › Sclérose en plaques › Deciphering the role of protein kinase A in...